Samphire Neuroscience

Samphire Neuroscience is a pioneering neurotechnology company focused on transforming women’s health. Its flagship product, Nettle™, is the first Class IIa CE-certified neuromodulation device developed to provide safe, drug-free relief for menstrual-related mood and pain symptoms, including those associated with PMDD, endometriosis, and chronic pelvic pain. Combining rigorous scientific development with user-centric design, Samphire delivers a solution that is effective, accessible, and easy to integrate into daily life. Nettle™ has seen rapid adoption and strong demand across Europe and the UK, with plans to expand into the US market. Samphire is setting a new standard in women’s health by addressing critical, historically overlooked needs for millions of women worldwide.

Fortify Ventures co-led Samphire’s $5 million seed round to help tackle one of the largest and most persistent challenges in women’s health.